THE Food and Drug Administration (FDA) on Friday, January 24, 2025, advised all health product establishments and their ...

VMD response to concerns raised following media reports of serious adverse events in cats administered Solensia. The VMD is aware of media reports and ...

The use of the ESMP will become mandatory for MAHs and NCAs as of Sunday, February 2. The platform is a key requirement of ...

Chugai in-licensed Tarceva from Roche and is the marketing authorization holder in Japan. Chugai has been marketing Tarceva and providing information in Japan since 2007. In consideration of the ...

Junshi Biosciences and TopAlliance are set to enter a collaboration with LEO Pharma to distribute and market toripalimab in ...

The Food and Drug Administration (FDA) has warned the public against buying and using beauty soaps made under the brand of ...

The public has been warned by the Food and Drug Administration (FDA) against buying and using beauty soaps made under the ...

Pharma: Launch of Shortages Monitoring Platform, several Changes re Clinical Trial Management in EU Countries; Devices: Resolution on the need ...

Junshi Biosciences enters distribution and marketing partnership with LEO Pharma for toripalimab in Europe: Shanghai, China Wednesday, January 22, 2025, 14:00 Hrs [IST] Shanghai J ...

Min Son of Hanol IP & Law says pharmaceutical R&D in South Korea should be enhanced on the introduction of a clearer legal ...

Detailed price information for Outlook Therapeutics Inc (OTLK-Q) from The Globe and Mail including charting and trades.

These can include assurance of 24/7 cover, local presence, and local language. While marketing authorisation holders (MAHs) are striving to standardise PV processes as much as possible ...